(Q37918962)

25 August 2017

1 reference

title

The osteoclast--what's new? (English)

1 reference

25 August 2017

Nicolas A Athanasou

1

1 reference

25 August 2017

publication date

17 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

40

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

1137-1140

1 reference

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Osteoclasts: what do they do and how do they do it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

The molecular understanding of osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Molecular regulation of osteoclast activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

21 January 2018

Paget disease of bone

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Estrogen deficiency and bone loss: an inflammatory tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

TGF-β in cancer and bone: implications for treatment of bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-011-1180-9

Canonical and non-canonical pathways of osteoclast formation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21847745

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cellular biology of bone-resorbing cells.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21847745

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Do all Paget disease risk genes incriminate the osteoclast?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21847745

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00256-011-1180-9

1 reference

25 August 2017

1 reference